What is B. Riley’s Forecast for NKTR FY2024 Earnings?

3 days ago · Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at B. Riley issued their FY2024 earnings estimates for Nektar Therapeutics in a research report issued to clients and investors on ...

$4.00
OFF

Nektar Therapeutics (NKTR) Gets A Buy From B.Riley Financial

2 weeks from now

Jan 8, 2025 · Nektar Therapeutics (NKTR – Research Report) received a Buy rating and a $4.00 price target from B.Riley Financial analyst Mayank Mamtani yesterday. The company’s shares …

businessinsider.com

86%
OFF

B. Riley Securities Initiates Coverage Of Nektar Therapeutics (NKTR ...

2 weeks from now

Dec 23, 2024 · Analyst Price Forecast Suggests 302.86% Upside As of December 23, 2024, the average one-year price target for Nektar Therapeutics is $4.79/share. The forecasts range …

nasdaq.com

14%
OFF

B. Riley Stock Jumps After Submitting Q2 2024 Filing

2 weeks from now

1 day ago · B. Riley Financial (NASDAQ:RILY) stock surged 14% in Tuesday premarket trading after the company filed its 10-Q for Q2 2024, disclosing the financial impacts of actions it had …

seekingalpha.com

$2.83
OFF

What Is B. Riley's Forecast For BCYC FY2024 Earnings? - MarketBeat

2 weeks from now

Nov 20, 2024 · B. Riley analyst K. Patel now expects that the company will post earnings per share of ($2.83) for the year, down from their prior forecast of ($2.33). B. Riley currently has a …

marketbeat.com

$0.62
OFF

B. Riley Research Analysts Lift Earnings Estimates For BTDR

2 weeks from now

Dec 23, 2024 · Riley analyst L. Pipes now expects that the company will post earnings of ($0.62) per share for the year, up from their prior forecast of ($0.68). B. Riley currently has a “Buy” …

etfdailynews.com

$0.91
OFF

B. Riley Has Strong Forecast For Reddit FY2025 Earnings

2 weeks from now

21 hours ago · B. Riley analyst N. Khan now expects that the company will post earnings per share of $0.91 for the year, up from their prior forecast of $0.90. B. Riley currently has a "Buy" …

marketbeat.com

$0.23
OFF

What Is B. Riley’s Forecast For NR FY2024 Earnings?

2 weeks from now

Nov 16, 2024 · Riley analyst A. Rygiel expects that the oil and gas company will post earnings of $0.23 per share for the year. The consensus estimate for Newpark Resources’ current full …

etfdailynews.com

$2.59
OFF

B. Riley Equities Analysts Cut Earnings Estimates For SIMO

2 weeks from now

4 days ago · The consensus estimate for Silicon Motion Technology’s current full-year earnings is $2.59 per share. B. Riley also issued estimates for Silicon Motion Technology’s Q1 2025 …

etfdailynews.com

$0.11
OFF

B. Riley Forecasts Aspen Aerogels FY2024 Earnings

2 weeks from now

4 days ago · The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. B. Riley also issued estimates for Aspen Aerogels’ Q4 2024 earnings at $0.14 EPS, Q1 …

etfdailynews.com

$2.59
OFF

What Is B. Riley's Forecast For SIMO FY2024 Earnings? - MarketBeat

2 weeks from now

6 days ago · The consensus estimate for Silicon Motion Technology's current full-year earnings is $2.59 per share. B. Riley also issued estimates for Silicon Motion Technology's Q1 2025 …

marketbeat.com

FAQs about What is B. Riley’s Forecast for NKTR FY2024 Earnings? Coupon?

How much did Riley Financial lose in Q3 2024?

Net loss attributable to B. Riley Financial (RILY) amounted to $433.6M vs. net income of $44.4M in the year-ago period. That translated to EPS of -$14.35 vs. $1.55 a year ago. As previously reported, the company expects to file the quarterly report for its Q3 2024 soon. ...

Why did Riley Financial stock surge 14% in premarket trading?

B. Riley Financial (NASDAQ: RILY) stock surged 14% in Tuesday premarket trading after the company filed its 10-Q for Q2 2024, disclosing the financial impacts of actions it had previously reported for shoring up its balance sheet. ...

Should you buy Nektar Therapeutics (NKTR)?

Nektar Therapeutics (NKTR – Research Report) received a Buy rating and a $4.00 price target from B.Riley Financial analyst Mayank Mamtani yesterday. The company’s shares closed yesterday at $1.19. Mamtani covers the Healthcare sector, focusing on stocks such as Novavax, Harrow Health, and Arrowhead Pharmaceuticals. ...

How much cash does B Riley have in 2024?

@battered As of December 31, 2024, B. Riley disclosed a preliminary cash balance of $257 million, which includes the amount reserved for the payment of the Company's February 2025 Senior Notes. @battered says 1 year and they are due? So it’s coming. Long m. Below comment buying them back below par. @RWilliam RILYM due next month ...

How do I receive news & ratings for Nektar Therapeutics?

Receive News & Ratings for Nektar Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nektar Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter. ...

How much loss is Riley exposed to?

Riley (RILY) said the maximum amount of loss that it's exposed to loss from loans receivable concentration is equivalent to the fair value of those loans, which totaled $144.8M. It's also exposed to a concentration of risk related to Freedom VCM, which totaled $121.6M as of June 30, 2024. ...